Organogenesis

ORGONasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$190.438 M

$1.48 +5.71%

Close of 22 Sept 2026

Revenue

$564.2M

#1848 by revenue

Earnings

$37.0M

#1681 by earnings

Shares outstanding

128,674,548

Latest filing cover page

P/E ratio

5.1

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#269Oramed PharmaceuticalsORMP$197.6M
#270Canton StrategicCNTN$195.2M
#271OrganogenesisORGO$190.4M
#272Satellos BioscienceMSLE$188.2M
#273NovaBridge BiosciencesNBP$183.5M

What if Organogenesis were worth as much as…

Open the what-if tool →

Gold $30.2T

$234,964.65

Per share 158,760× higher

Bitcoin $1.74T

$13,535.35

Per share 9,146× higher

Nvidia $5.52T

$42,866.03

Per share 28,964× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Organogenesis are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.